Some compounding pharmacies also offer sublingual (under-the-tongue) formulations, but these have not been extensively studied and the FDA has raised concerns about salt-form variations
If you want to compare switch scenarios, our dose conversion guide for semaglutide transitions can help you understand how providers think through these changes
When splitting these compound formulations, you are also splitting the supplemental ingredients
A trustworthy platform should offer: A named, identifiable prescribing physician (not just licensed providers) Screening for conditions that make semaglutide unsafe for you A dosing plan that changes based on your response A clear process for reporting side effects or complications Before you receive your prescription, you may want to ask the following: Whose name is on my prescription
Long-term success follows systems, not just drugs: studies and program reports show roughly 75% of participants experience significant weight loss on GLP-1 medications, and about 60% maintain weight loss long term when behavioral anchors and monitoring are included, so tracking the first 8 to 12 weeks is critical
Semaglutide has a longer elimination half-life than tirzepatide
